Our Technology
Currently Available
Under Development
AvantBio's
"Next Gen" Technology
Chemically Defined
Animal /Human Origin-Free (cdAOF)
Applications in Basic and Preclinical Laboratory Research
- 2D Human Fibroblast and Other Mesenchymal Cell Cultures
- Skin-derived Dermal fibroblasts
- Cornea-derived Stromal Fibroblasts (Keratocytes)
- Dermal Fibroblasts as Precursor Cells for Induced Pluripotent Stem Cells (iPSCs)
- Diploid Fetal Lung-derived Fibroblasts (e.g., WI-38)
- Hair Follicle Dermal Papilla Cells (HFDPC)
- 3D Bioprinted, Automated or Manually Reconstructed Connective Tissue, Using Human Fibroblasts
- Connective Tissue (e.g., Skin Dermis, Corneal Stroma)
- Other Connective Tissues
- Tissue on a Chip (e.g., Skin Dermis, Corneal Stroma)
Clinical Applications in Regenerative and Esthetic Medicine Using Dermal Fibroblasts and Other Mesenchymal Cells
- 2D Cell-based Therapies (e.g. Cutaneous, Cornea, Other)
- 2D Cell-derived Therapeutic Products (e.g., Conditioned Medium and Exosomes)
- 3D Reconstructed Connective Tissue Therapies (e.g. Cutaneous, Cornea, Other)
Cosmeceutical Applications Using Dermal Fibroblasts and Other Mesenchymal Cells
- Cell-derived Cosmeceutical Products (e.g., Conditioned Medium and Exosomes)
RESEARCH COLLABORATIONS, PARTNERING aND INVESTMENT
Let’s explore the possibilities!
Are you intrigued by the cutting-edge technologies developed by AvantBio? We’re eager to connect with potential partners and investors and explore new collaborative opportunities. Whether you are interested in investment, have a specific project in mind or simply want to learn more about how we can work together, we invite you to get in touch with us. You can send us an email at busdev@avantbio.com or visit our “Contact Us” page to provide additional information about your interests.
